German pharma specializing in importation & wholesale of medical cannabis facing questions after claims they are distributing different cannabis cultivars under the same marketing authorization numbers and drug names.

If the Germans are doing it, it really doesn’t give me much confidence about any other jurisdiction. StratCann have the story First, in a letter dated August 26, 2025, an international law firm issued a warning to Remexian Pharma GmbH, accusing them of distributing cannabis cultivars in Germany’s medical cannabis market under identical marketing authorization numbers […]